Neuroprotective Nanoparticles Targeting the Retina: A Polymeric Platform for Ocular Drug Delivery Applications

Area of Science:

• Ophthalmology
• Nanotechnology
• Neuroscience

Background:

• Delivering neuroprotective drugs to the posterior eye is challenging.
• Polymer-based nanocarriers offer potential for targeted ocular drug delivery.
• Retinal degeneration leads to vision loss and requires effective treatments.

Purpose of the Study:

• To develop and evaluate a polymer-based nanocarrier for targeted neuroprotection in the posterior eye.
• To conjugate polyacrylamide nanoparticles (ANPs) with peanut agglutinin (PNA) and nerve growth factor (NGF) for enhanced ocular targeting and neuroprotection.
• To assess the efficacy of the ANP:PNA:NGF system in zebrafish models of retinal degeneration.

Main Methods:

• Synthesis and characterization of polyacrylamide nanoparticles (ANPs).
• Conjugation of ANPs with peanut agglutinin (PNA) and nerve growth factor (NGF) to form ANP:PNA:NGF.
• Evaluation of ANP:PNA:NGF neuroprotective activity in zebrafish larvae using oxidative stress (hydrogen peroxide) and cigarette smoke extract (CSE) models.
• Assessment of visual function and retinal cell apoptosis in treated zebrafish.

Main Results:

• The ANP:PNA:NGF formulation demonstrated improved visual function in zebrafish larvae after intravitreal hydrogen peroxide injection.
• Nanoformulation led to a reduction in apoptotic cells in the retina.
• ANP:PNA:NGF effectively counteracted visual behavior impairment in zebrafish exposed to cigarette smoke extract.
• The nanocarrier system showed high binding efficiency for ocular targeting.

Conclusions:

• The developed polymeric drug delivery system (ANP:PNA:NGF) shows promise for targeted treatment of posterior eye diseases.
• This nanocarrier strategy can enhance neuroprotection and visual function in retinal degeneration models.
• The findings support the potential of nanotechnology in addressing challenges in ocular drug delivery and treating vision loss.